Ubs Asset Management Americas Inc Atri Cure, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,196,914 shares of ATRC stock, worth $71.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,196,914
Previous 811,370
170.77%
Holding current value
$71.9 Million
Previous $24.8 Million
185.83%
% of portfolio
0.02%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding ATRC
# of Institutions
237Shares Held
51.9MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$154 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$151 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$120 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$98.1 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$79.7 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.52B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...